Second Opinion BLOG
On Wednesday April 2, 2014 at 6:30pm Second Opinion will screen at the a/perture cinema in Winston-Salem, NC More info (336) 722-8148 Eric Merola will attend and participate in a Q&A afterward. – BUY TICKETS NOW – SELL OUT IS EXPECTED – On Sunday April 6, 2014 at 12:15 pm Second Opinion will screen at […]
Ralph W. Moss, PhD was co-founder of the National Institutes of Health’s Office Of Alternative Medicine and also served as their advisor from 1991-2001. Dr. Moss was also Assistant Director of Public Affairs at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City when he unveiled a cover-up of positive tests with America’s most controversial anticancer agent, Laetrile. He was ordered by MSKCC officials to falsify reports. He refused. Instead, he organized an underground employee group called Second Opinion to oppose this cover-up.
Eric Merola, the internationally award-winning director of the Burzynski Film Series, is proud to announce the release of his third documentary — Second Opinion: Laetrile At Sloan-Kettering — which takes you through a detailed journey of these shocking events.
“Eric Merola is a bright and talented filmmaker.”
Dr. Mehmet Oz – The Dr. Oz Show
Ralph W. Moss, PhD has also simultaneously released Doctored Results — a new book and companion guide to this documentary.
Read what medical professionals have to say about Dr. Moss’ new book — illustrating his first-hand account of this story:
“Ralph W. Moss has stayed the course in stating his case. I am glad his voice is being heard.”
Harold P. Freeman, MD
Past National President, American Cancer Society and Past Chairman, President’s Cancer Panel.
“A remarkable and readable description of the laetrile controversy.”
Michael Retsky, PhD
Harvard School of Public Health, Boston, MA
“A spellbinding story of a scientist who was subjected to tremendous pressure and criticism after he unexpectedly validated an unconventional agent that inhibited metastasis.”
Peter L. Peterson, PhD
Professor, Dept. of Biological Chemistry and Oncology
Johns Hopkins University School of Medicine, Baltimore, MD
“Cancer care in America is controlled by big business and this riveting first-hand account is a real exposé of what can happen when science and business clash.”
Damian E. Dupuy, MD, Director of Tumor Ablation, Rhode Island Hospital and Professor of Radiology, The Warren Alpert School of Medicine of Brown University, Providence, RI
“Moss raises important and troubling questions about the objectivity with which Memorial Sloan-Kettering presented research data on laetrile, a controversial cancer treatment. ‘Doctored Results’ is well documented, challenging, and painfully sobering. It should be required reading for all who hope to make the most effective cancer treatments available to Americans.”
James S. Gordon, MD, Chair of the Program Advisory Council to the National Institutes of Health’s Office of Alternative Medicine, Washington, DC
Bharat B. Aggarwal, PhD
Professor, Department of Experimental Therapeutics
The University Of Texas M.D.Anderson Cancer Center, Houston, TX
“An instant classic.”
Michael Schachter, MD
Past President, American College for Advancement in Medicine
“An anatomy of a cancer establishment cover-up, followed by the ‘murder’ of a promising anti-cancer drug.”
Tibor Bakacs, MD, PhD, DSc
National Academy of Sciences, Budapest, Hungary
“This book shows how potentially useful discoveries can be hidden from an uninformed public when the stakes are high enough.”
T. Colin Campbell, PhD
Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry, Cornell University, Ithaca, NY, and author of The China Study
“I couldn’t put down Doctored Results—it reads like a medical thriller. Ralph Moss, who blew the whistle on the misdeeds of his ‘superiors’ at Sloan-Kettering Institute, discusses the astonishing results with laetrile at Sloan-Kettering and shows how the public’s perception of this therapy was manipulated by the powers-that-be for their own selfish ends. Doctored Results is a must-read book for everyone interested in complementary medicine.”
Julian Whitaker, MD, Director, Whitaker Wellness Institute and Editor, Health & Healing Newsletter, Newport Beach, California.
The story of Laetrile has a long history starting in San Luis Obispo (SLO) — making the World Premiere of “Second Opinion” in SLO a logical fit. Notice the photo below. SLO’s old pharmacy from the turn of the 19th century was owned and operated by Dr. Ernst Krebs, the original inventor of Laetrile.
Ralph W. Moss, PhD — the hero of “Second Opinion” as well as the film’s director Eric Merola will attend both screenings and participate in a Q&A afterwards.
(This is an excerpt from “Doctored Results”, a new book by Ralph W. Moss, PhD – a great companion to the documentary “Second Opinion: Laetrile At Sloan-Kettering.”) The War on Cancer The US government had had an organized cancer research program since passage of the National Cancer Institute (NCI) Act in 1937. By the late […]
SECOND OPINION was shot over the course of a year in various locations, including the historical Aldrich House in Providence, RI, New York City, and State College, PA.
This documentary is the film Eric Merola has always wanted to make. The hero of our story, Ralph W. Moss, PhD, wrote a book entitled “The Cancer Industry”, which covers many of the experiences he describes in SECOND OPINION. Merola read the book back in 2007, and was so taken by Moss’ story, that it inspired him to direct his first documentary.
Learning from the process of shooting two documentaries himself, Merola decided to step up the production quality on SECOND OPINION by hiring some of the industry’s top DPs and musical talent. And since all of his previous films had been self-funded, the financial success of the first two documentaries allowed Merola the ability to create his first top notch, well-funded film—SECOND OPINION.
The story of SECOND OPINION is one of a whistle-blower who followed his conscience instead of his paycheck to do what he believed was morally right. It could have been about any subject, but the fact that it pertains to an unmarketable cancer therapy that was testing positively within the confines of America’s largest cancer research institution at the time, and then was forced to be suppressed for profit reasons by the highest levels of government, makes for a very timely and relevant story in a time of ever-increasing corruption and secrecy by both industry and government.